Though lung cancer looks promising a partner is now needed.
ApexOnco Front Page
Recent articles
Deteriorating efficacy and a treatment-related death with Zynlonta plus Columvi spook investors.
After more discontinuations, a new deal brings in fresh blood.
Harmoni-A hits, backing a quiet disclosure about the Harmoni trial.
Inhibrx reveals three deaths in phase 1, but all predate screening protocols.
BG-75202 features among several projects starting first-in-human trials.
There will soon be three PD-(L)1 x VEGF projects in pivotal lung and colorectal cancer trials.
Pfizer cans PF-08046045, but keeps PF-08046044 for now.
